A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 182 participants.
Also called NCT01054092
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 182 participants
- Sponsor
- Registry
-
NCT01054092
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01054092. Randomized; no masking; primary purpose treatment. Start 2010-01-14 (actual); primary completion 2011-07-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ipragliflozin
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01054092- Content hash
05f32eb7effed2ae90c5ee2f649bbe83eab26e07ac185e9db1933935dabdfbfa